HHCV 9(R)-Hexahydrocannabivarin cas: 853700-63-4

CAS NO: 853700-63-4
9β-Hexahydrocannabinol
11β-Hexahydrocannabinol
cas: 36403-90-4
9β-HHC
9(R)-HHC
11β-HHC
trans-(6aR,9R,10aR)-HHC
Description Review
Description




HHCV 9(R)-Hexahydrocannabivarin is a synthetic cannabinoid that has gained attention in the medical field for its potential health benefits. Its chemical name is (6aR,10aR)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran and its molecular formula is C25H36O2. It has a formula weight of 368.55 g/mol and its CAS number is 853700-63-4.
Introducing HHCV 9(R)-Hexahydrocannabivarin HHCV 9(R)-Hexahydrocannabivarin is an intriguing and comparatively unknown molecule in the rapidly developing field of cannabis research. The purpose of this article is to offer insight on its chemical composition, prospective uses, and safety profile.

Here are some top ten keywords and synonyms related to HHCV 9(R)-Hexahydrocannabivarin:

Keywords:

  • Synthetic cannabinoid
  • Medical marijuana
  • Cannabinoid receptor agonist
  • Neuroprotection
  • Anti-inflammatory
  • Antioxidant
  • Pain relief
  • Anxiety
  • Depression
  • THC alternative
  • Search Terms on Google "Properties of HHCV 9(R)-Hexahydrocannabivarin," "Research on HHCV cannabinoids," "Pharmacology of Hexahydrocannabivarin," "Effects and uses of 9(R)-HHCV" Other products in the market CBD (Cannabidiol) and THC (Tetrahydrocannabinol), both of which are recognized cannabinoids with distinct properties and applications, are comparable products in this domain.

Synonyms:

  • HHC
  • Hexyl homologue of cannabidiol
  • Cannabivarin analogue
  • Cannabivarin hydrazide
  • Cannabivarin derivative
  • Cannabivarin dimethylheptyl
  • CBV-HHC
  • 9(R)-HHCV
  • 9(R)-hexahydrocannabivarin
  • 3-(1,1-Dimethylheptyl)-9,9-dimethyl-2,3,4,5,6,7-hexahydro-1H-benzo[b]azepin-1-one

Possible Effects and Health Benefits
The exact medicinal uses of HHCV are still up for debate, although its structural similarities to other cannabinoids imply it may have anti-inflammatory, mood-regulating, or pain-relieving capabilities, among other possible uses.


Product Mechanism
It is believed that HHCV, like other cannabinoids, interacts with the endocannabinoid system, which in turn influences a variety of physiological processes because of this interaction. Nevertheless, further investigation would be required to determine the precise process.


What are the risks and effects?
Given the novelty of HHCV, its safety profile and possible adverse effects are not thoroughly characterized. It must be used with caution and undergo additional scientific validation prior to being designated secure.


Information on Dosing
Dosage recommendations for HHCV have not been developed due to a lack of clinical trials. When doing any kind of experiment, it is important to start with little quantities.


Important Considerations
Similar to other cannabinoids, contraindications depend on health conditions and drugs.


In summary
A fascinating new direction in cannabis research is represented by HHCV 9(R)-Hexahydrocannabivarin. As scientists continue to solve its riddles, it offers the prospect of improving our knowledge and use of cannabinoid-based chemicals.


People Also ask
What is the legal standing of hexahydrocannabivarin, or HHCV 9(R)?
A: The legal position of new cannabinoids such as HHCV differs by jurisdiction and is susceptible to change. Current local laws and regulations must be fully consulted.

Q: Can HHCV be used to treat illnesses?
Medical usage of HHCV is not warranted in the absence of clinical proof. The possibility of its use as a medicinal agent is still a subject of investigation for the foreseeable future.


Q: How does HHCV compare to CBD?
A: Although HHCV and other cannabinoids, such as CBD, have similar chemical backgrounds, more study is necessary to precisely understand the exact effects and qualities of HHCV.


  1. "HHCV 9(R)-Hexahydrocannabivarin analysis,"
  2. "Cannabinoid HHCV effects,"
  3. "Hexahydrocannabivarin research,"
  4. "9(R)-HHCV cannabinoid properties,"
  5. "New cannabinoids HHCV legal status,"
  6. "HHCV safety and toxicity,"
  7. "Medical applications of Hexahydrocannabivarin,"
  8. "HHCV 9(R) pharmacology,"
  9. "Cannabinoid system interaction with HHCV,"
  10. "Hydrogenated cannabinoid HHCV studies."
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code